About

Publications While At HealthPartners

selected publications

Journal Article

Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. 

Diabetes care. 2010

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. 

Lancet (London, England). 2008

Review

The safety of incretin-based therapies--review of the scientific evidence [review]. 

Journal of Clinical Endocrinology and Metabolism. 2011

Contact

full name

D. J. Drucker

Quick Info

 

Collaboration

Co-author network

Map of science